Cirrhosis secondary to any cause will be excluded
History or evidence of cirrhosis
Patients who have cirrhosis at a level of Child-Pugh B (or worse) or cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis
Cirrhosis at a level of Child-Pugh B (or worse) or cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis (i.e. ascites from cirrhosis requiring diuretics or paracentesis)
Cirrhosis
History of cirrhosis
Cirrhosis.
Known cirrhosis or chronic hepatic failure
Exclude if patient has cirrhosis or is currently being actively treated for hepatitis C
Childs B or C cirrhosis
Known cirrhosis
The patient does not have cirrhosis at a level of Child-Pugh B (or worse) or cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis; clinically meaningful ascites is defined as ascites from cirrhosis requiring diuretics or paracentesis
The patient does not have: \r\n* Cirrhosis at a level of Child-Pugh B (or worse) or\r\n* Cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis; clinically meaningful ascites is defined as ascites from cirrhosis requiring diuretics or paracentesis
Have Child B/C cirrhosis
Cirrhosis at a level of Child-Pugh B (or worse) or cirrhosis (any degree) with a history of hepatic encephalopathy or clinical meaningful ascites resulting from cirrhosis; clinically meaningful ascites is defined as ascites resulting from cirrhosis and requiring ongoing treatment with diuretics and/or paracentesis
Clinical or pathological diagnosis of cirrhosis, hemochromatosis, or hepatic fibrosis
Primary hepatic dysfunction including known cirrhosis or active hepatitis. Patients with biliary obstruction must be stented prior to initiating treatment.
HCV genotype  treatment experienced with cirrhosis
Childs B or C cirrhosis
Clinical or laboratory evidence of cirrhosis
Patients having:\r\n* Cirrhosis at a level of Child-Pugh B (or worse) or\r\n* Cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis; clinically meaningful ascites is defined as ascites from cirrhosis requiring diuretics or paracentesis
cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis
Cirrhosis or portal hypertension
biliary cirrhosis
cirrhosis (any degree) and a history of hepatic encephalopathy or clinically meaningful ascites resulting from cirrhosis. Clinically meaningful ascites is defined as ascites resulting from cirrhosis and requiring ongoing treatment with diuretics and/or paracentesis.
Known cirrhosis
Have any evidence of hepatic cirrhosis or clinical or radiographic ascites
Have any evidence of hepatic cirrhosis or clinical or radiographic ascites
Hepatocellular disease (eg, cirrhosis)
Decompensated cirrhosis
Clinical evidence of cirrhosis
Have any evidence of hepatic cirrhosis or clinical or radiographic ascites
Patients with known cirrhosis
Patients with known cirrhosis
Known hepatic cirrhosis
Patients with known cirrhosis.
History of cirrhosis
Have any evidence of hepatic cirrhosis or clinical or radiographic ascites
cirrhosis (any degree) and a history of hepatic encephalopathy or ascites resulting from cirrhosis and requiring ongoing treatment with diuretics and/or paracentesis
Has cirrhosis at a level of Child-Pugh B (or worse), or cirrhosis and a history of hepatic encephalopathy, or ascites resulting from cirrhosis and requiring ongoing treatment with diuretics and/or paracentesis
Known cirrhosis
Diagnosis of cirrhosis based on one or more of the following: histology, US, computed tomography (CT) or MRI showing cirrhosis, +/- lesions seen on CE-MRI
Participants with a clinical diagnosis of cirrhosis based on the investigator's evaluation, confirmed by any one of following methods to define cirrhosis:\r\n* Established cirrhosis on liver biopsy (Meta-analysis of Histological Data in Viral Hepatitis [METAVIR] F);\r\n* Computed tomography (CT) or magnetic resonance imaging (MRI) findings consistent with cirrhosis; nodular appearing liver with or without evidence of portal hypertension\r\n* Transient elastography (FibroScan) with a result > . kPa\r\n* FibroScan score > . and aspartate aminotransferase (AST) to platelet ratio index (APRI) > \r\n* Etiology of cirrhosis will not be considered in determining inclusion in the study
Chronic renal diseases and hepatic cirrhosis
Diagnosis of cirrhosis
Cirrhosis, cardiomyopathy, restrictive heart disease, or bronzing of the skin
Subjects with known hepatic insufficiency or cirrhosis
Subjects with known hepatic insufficiency or cirrhosis
Participants with known hepatic insufficiency or cirrhosis
Subjects with known hepatic insufficiency or cirrhosis
Documented cirrhosis
Undiagnosed cirrhosis
